EULAR recommendations for the management of early arthritis: Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Jan
COMBE B, LANDEWE R, LUKAS C et al.: EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007 Jan; 66: 34-45.
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial
GRIGOR C, CAPELL H, STIRLING A et al.: Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004; 364: 263-269
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
on behalf of the British Society for Rheumatology, British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group in consultation with the British Association of Dermatologists (BAD). Oxford
CHAKRAVARTY K, MCDONALD H, PULLAR T et al.: on behalf of the British Society for Rheumatology, British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group in consultation with the British Association of Dermatologists (BAD). BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. Rheumatology (Oxford). 2008; 47: 1591.
Guidelines for the management of rheumatoid arthritis: American College of Rheumatology Ad Hoc Committee on Clinical Guidelines
GUIDELINES FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS: American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum 1996; 39: 713-722 (Pubitemid 126613842)
Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus
Epub 2008 Jan 8
GARCIA-GONZALEZ A, RICHARDSON M, GARCIA POPA-LISSEANU M et al.: Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 2008; 27: 883-889 [Epub 2008 Jan 8].
Barriers to treatment adherence among African American and white women with systemic lupus erythematosus
MOSLEY-WILLIAMS A, LUMLEY MA, GILLIS M, LEISEN J, GUICE D: Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum 2002; 47: 630-638
Determinants of compliance in rheumatoid arthritic patients assessed in their home environment
OWEN SG, FRIESEN WT, ROBERTS MS, FLUX W: Determinants of compliance in rheumatoid arthritic patients assessed in their home environment. Br J Rheumatol 1985; 24: 313-320
Determinants of compliance with medication in patients with rheumatoid arthritis: The importance of self-efficacy expectations
BRUS H, VAN DE LAAR M, TAAL E, RASKER J, WIEGMAN O: Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Couns 1999; 36: 57-64.